Study and report to Congress on increased cancer screening for women

(a) In general The Secretary of Health and Human Services (referred to in this section as the Secretary) shall— (1) conduct a study (and periodically update such study) on increased access to women’s preventive life-saving cancer screenings across the United States; and (2) not later than 2 years after the date of enactment of this Act, and every 5 years thereafter, submit a report to Congress on such study. (b) Contents The study and reports under subsection (a) shall include— (1) an analysis of breast and gynecologic cancer rates among women across all 50 States, the District of Columbia, and the territories, including by geographic area, income, employment status, race, ethnicity, and status of insurance coverage; (2) an analysis of cancer screenings provided by women’s health care providers across all 50 States, the District of Columbia, and the territories, including clinical breast exams, other screening for breast cancer, and screening for cervical cancer, ovarian cancer, and other gynecologic cancers; (3) with respect to women with disproportionate rates of gynecological cancers, or who are less likely to receive screenings and care, and broken down by categories of such women that include Black women; Hispanic and Latina women; Asian American, Native Hawaiian, and Pacific Islander women; older women; uninsured and underinsured women; and women living in rural and underserved areas— (A) an analysis of the awareness, availability, and uptake of breast, cervical, ovarian, and other gynecological cancer screening options; (B) an analysis of how access to health care providers trained under the program described in section 317P–2 of the Public Health Service Act, as added by section 5, in comparison to other health care providers, increased early detection of cancer and quality of cancer care for such women; and (C) recommendations for increasing screening rates for such women who are less likely to be screened or treated for breast, cervical, ovarian, and other gynecological cancers; (4) an analysis of how structural racism impacts access to cancer screening services, correlates to the development of breast, cervical, ovarian, and other gynecological cancers, and exacerbates health care disparities for Black women; Hispanic and Latina women; Asian American, Native Hawaiian, and Pacific Islander women; and other women of color; (5) in consultation with the Comptroller General of the United States, estimated Federal savings achieved through early detection of breast and gynecologic cancers; (6) recommendations by the Secretary with respect to the need for continued increased access to women’s health care providers, such as the entities described in section 317P–2(c) of the Public Health Service Act, as added by section 5, who provide preventive care, including life-saving cancer screenings; and (7) an evaluation of the demonstration project on co-testing for human papillomavirus and cervical cancer under section 317P–3 of the Public Health Service Act, as added by section 7, including the results of the demonstration project and a recommendation on whether expansion of the co-testing model described in such section 317P–3 would be advised in order to promote early intervention, screening uptake, and reduce cervical cancer deaths and racial and ethnic disparities.